Frontiers in Neuroscience,
Journal Year:
2020,
Volume and Issue:
14
Published: Aug. 6, 2020
The
blood-brain
barrier
(BBB)
is
a
dynamic
but
solid
shield
in
the
cerebral
microvascular
system.
It
plays
pivotal
role
maintaining
central
nervous
system
(CNS)
homeostasis
by
regulating
exchange
of
materials
between
circulation
and
brain,
protects
neural
tissue
from
neurotoxic
components
as
well
pathogens.
Here,
we
discuss
development
BBB
physiological
conditions
then
focus
on
cerebrovascular
disease,
including
acute
ischemic
stroke
intracerebral
hemorrhage,
neurodegenerative
disorders,
such
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
multiple
sclerosis
(MS).
Finally,
summarize
recent
advancements
therapies
targeting
outline
future
directions
outstanding
questions
field.
We
propose
that
dysfunction
not
only
results
causal
pathogenesis
neurological
disorders;
more
contributor
to
disruption
CNS
than
victim
disorders.
Frontiers in Cellular Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: Aug. 16, 2021
Brain
edema
is
a
severe
stroke
complication
that
associated
with
prolonged
hospitalization
and
poor
outcomes.
Swollen
tissues
in
the
brain
compromise
cerebral
perfusion
may
also
result
transtentorial
herniation.
As
physical
biochemical
barrier
between
peripheral
circulation
central
nervous
system
(CNS),
blood–brain
(BBB)
plays
vital
role
maintaining
stable
microenvironment
of
CNS.
Under
pathological
conditions,
such
as
ischemic
stroke,
dysfunction
BBB
results
increased
paracellular
permeability,
directly
contributing
to
extravasation
blood
components
into
causing
vasogenic
edema.
Recent
studies
have
led
discovery
glymphatic
meningeal
lymphatic
vessels,
which
provide
channel
for
cerebrospinal
fluid
(CSF)
enter
drain
nearby
lymph
nodes
communicate
immune
system,
modulating
surveillance
responses.
A
deeper
understanding
function
calls
question
known
mechanisms
after
stroke.
In
this
review,
we
first
discuss
how
disruption
can
cause
or
contribute
from
perspective
molecular
cellular
pathophysiology.
Finally,
participates
formation
summarize
pathophysiological
process
two
directions
system.
Fluids and Barriers of the CNS,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: July 19, 2024
Abstract
Background
Maintaining
the
structural
and
functional
integrity
of
blood–brain
barrier
(BBB)
is
vital
for
neuronal
equilibrium
optimal
brain
function.
Disruptions
to
BBB
performance
are
implicated
in
pathology
neurodegenerative
diseases.
Main
body
Early
indicators
multiple
disorders
humans
animal
models
include
impaired
stability,
regional
cerebral
blood
flow
shortfalls,
vascular
inflammation
associated
with
dysfunction.
Understanding
cellular
molecular
mechanisms
dysfunction
crucial
elucidating
sustenance
neural
computations
under
pathological
conditions
developing
treatments
these
This
paper
initially
explores
definition
BBB,
along
signaling
pathways
regulating
flow,
inflammation.
Subsequently,
we
review
current
insights
into
dynamics
Alzheimer’s
disease,
Parkinson's
amyotrophic
lateral
sclerosis,
sclerosis.
The
concludes
by
proposing
a
unified
mechanism
whereby
contributes
disorders,
highlights
potential
BBB-focused
therapeutic
strategies
targets,
outlines
lessons
learned
future
research
directions.
Conclusions
breakdown
significantly
impacts
development
progression
diseases,
unraveling
underlying
elucidate
how
sustained
devise
approaches.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: March 3, 2025
Abstract
Mitochondrial
diseases
represent
one
of
the
most
prevalent
and
debilitating
categories
hereditary
disorders,
characterized
by
significant
genetic,
biological,
clinical
heterogeneity,
which
has
driven
development
field
engineered
mitochondria.
With
growing
recognition
pathogenic
role
damaged
mitochondria
in
aging,
oxidative
inflammatory
diseases,
cancer,
application
expanded
to
those
non-hereditary
contexts
(sometimes
referred
as
mitochondria-related
diseases).
Due
their
unique
non-eukaryotic
origins
endosymbiotic
relationship,
are
considered
highly
suitable
for
gene
editing
intercellular
transplantation,
remarkable
progress
been
achieved
two
promising
therapeutic
strategies—mitochondrial
artificial
mitochondrial
transfer
(collectively
this
review)
over
past
decades.
Here,
we
provide
a
comprehensive
review
mechanisms
recent
advancements
applications,
alongside
concise
summary
potential
implications
supporting
evidence
from
preclinical
studies.
Additionally,
an
emerging
potentially
feasible
approach
involves
ex
vivo
editing,
followed
selection
holds
overcome
limitations
such
reduced
operability
introduction
allogeneic
thereby
broadening
applicability
Proceedings of the National Academy of Sciences,
Journal Year:
2020,
Volume and Issue:
117(9), P. 4959 - 4970
Published: Feb. 18, 2020
Significance
Necroptosis
has
been
defined
as
a
regulated
cell
death
mechanism
that
can
be
activated
under
apoptosis
deficient
conditions.
Here
we
show
necroptosis
brain
ischemic
conditions
without
inhibition
of
apoptosis.
Furthermore,
neuronal
followed
by
delayed
after
the
reduction
TAK1
Our
study
demonstrates
complex
interaction
and
insult
suggests
therapeutic
targeting
RIPK1
kinase
for
treatment
stroke.
Frontiers in Physiology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 22, 2020
Ischemic
stroke,
a
major
cause
of
mortality
in
the
United
States,
often
contributes
to
disruption
blood-brain
barrier
(BBB).
The
BBB
along
with
its
supportive
cells,
collectively
referred
as
“neurovascular
unit,”
is
brain’s
multicellular
microvasculature
that
bi-directionally
regulates
transport
blood,
ions,
oxygen,
and
cells
from
circulation
into
brain.
It
thus
vital
for
maintenance
central
nervous
system
homeostasis.
disruption,
which
associated
altered
expression
tight
junction
proteins
transporters,
believed
exacerbate
brain
injury
caused
by
ischemic
stroke
limits
therapeutic
potential
current
clinical
therapies,
such
recombinant
tissue
plasminogen
activator.
Accumulating
evidence
suggests
endothelial
mechanobiology,
conversion
mechanical
forces
biochemical
signals,
helps
regulate
function
peripheral
vasculature
may
similarly
maintain
integrity.
For
example,
glycocalyx
(GCX),
glycoprotein-proteoglycan
layer
extending
lumen
bloods
vessel,
abundantly
expressed
on
has
been
shown
permeability.
In
this
review,
we
will
focus
our
understanding
mechanisms
underlying
damage
after
highlighting
future
novel
pharmacological
strategies
protection
recovery.
Finally,
address
knowledge
mechanotransduction
maintenance,
specifically
focusing
role
GCX.
Fluids and Barriers of the CNS,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: March 16, 2020
Abstract
The
blood–brain
barrier
(BBB)
is
a
fundamental
component
of
the
central
nervous
system.
Its
functional
and
structural
integrity
vital
in
maintaining
homeostasis
brain
microenvironment.
On
other
hand,
BBB
also
major
hindering
obstacle
for
delivery
effective
therapies
to
treat
disorders
Central
Nervous
System
(CNS).
Over
time,
various
model
systems
have
been
established
simulate
complexities
BBB.
development
realistic
vitro
models
that
accurately
mimic
physiological
characteristics
microcapillaries
situ
importance
not
only
CNS
drug
discovery
but
translational
research.
Successful
modeling
Neurovascular
Unit
(NVU)
would
provide
an
invaluable
tool
aid
dissecting
out
pathological
factors,
mechanisms
action,
corresponding
targets
prodromal
onset
disorders.
field
has
seen
many
changes
last
few
years
with
introduction
novel
tools
methods
improve
existing
enable
new
ones.
organoids,
organ-on-chip,
spheroids,
3D
printed
microfluidics,
innovative
technologies
potential
advance
NVU
modeling.
Therefore,
this
review,
summarize
advances
progress
design
application
platforms
focus
on
rapidly
advancing
technologies.